Barclays
ANAC

Barclays’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Barclays’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,828
Closed -$256K – 7047
2016
Q1 		$256K Sell
4,828
-47,283
-91% -$3.49M ﹤0.01% 3666
2015
Q4 		$5.84M Buy
52,111
+38,451
+281% +$4.24M 0.01% 1216
2015
Q3 		$1.6M Buy
13,660
+10,756
+370% +$1.4M ﹤0.01% 2316
2015
Q2 		$223K Sell
2,904
-14,187
-83% -$930K ﹤0.01% 4076
2015
Q1 		$974K Buy
17,091
+13,021
+320% +$553K ﹤0.01% 3004
2014
Q4 		$129K Sell
4,070
-980
-19% -$29.4K ﹤0.01% 4985
2014
Q3 		$121K Sell
5,050
-3,745
-43% -$76.1K ﹤0.01% 5188
2014
Q2 		$150K Sell
8,795
-11,992
-58% -$193K ﹤0.01% 5113
2014
Q1 		$416K Buy
20,787
+17,467
+526% +$339K ﹤0.01% 4111
2013
Q4 		$53K Sell
3,320
-29,972
-90% -$415K ﹤0.01% 6144
2013
Q3 		$332K Buy
33,292
+27,206
+447% +$238K ﹤0.01% 4544
2013
Q2 		$34K Buy
+6,086
New +$36.9K ﹤0.01% 6565

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Barclays's ANAC Position: Q2 2016 in Review

Barclays sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,828 shares — an estimated $256K sold.

Barclays first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $5.84M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Barclays reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Barclays sold 4,828 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $256K.
  • Barclays first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Barclays's ANACOR PHARMACEUTICALS INC COM position peaked at $5.84M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.